BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9255791)

  • 1. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.
    Ohno K; Sawai K; Iijima Y; Levin B; Meruelo D
    Nat Biotechnol; 1997 Aug; 15(8):763-7. PubMed ID: 9255791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Sindbis virus-based vectors to Fc receptor-positive cell types.
    Klimstra WB; Williams JC; Ryman KD; Heidner HW
    Virology; 2005 Jul; 338(1):9-21. PubMed ID: 15922395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector.
    Sawai K; Meruelo D
    Biochem Biophys Res Commun; 1998 Jul; 248(2):315-23. PubMed ID: 9675133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a Sindbis virus vector displaying an immunoglobulin-binding domain: antibody-dependent infection of neurons in living mice.
    Konno A; Honjo T; Uchida A; Ishizuka T; Yawo H
    Neurosci Res; 2011 Dec; 71(4):328-34. PubMed ID: 21925217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.
    Altman-Hamamdzic S; Groseclose C; Ma JX; Hamamdzic D; Vrindavanam NS; Middaugh LD; Parratto NP; Sallee FR
    Gene Ther; 1997 Aug; 4(8):815-22. PubMed ID: 9338010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells.
    Ojala K; Mottershead DG; Suokko A; Oker-Blom C
    Biochem Biophys Res Commun; 2001 Jun; 284(3):777-84. PubMed ID: 11396970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient delivery of antibody into living cells using a novel HVJ envelope vector system.
    Kondo Y; Fushikida K; Fujieda T; Sakai K; Miyata K; Kato F; Kato M
    J Immunol Methods; 2008 Mar; 332(1-2):10-7. PubMed ID: 18221753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of Sindbis virus vectors produced with a chimeric split helper system.
    Ketola A; Schlesinger S; Wahlfors J
    Int J Mol Med; 2005 Jun; 15(6):999-1003. PubMed ID: 15870906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing cytotoxicity induced by Sindbis viral vectors.
    Sawai K; Ikeda H; Ishizu A; Meruelo D
    Mol Genet Metab; 1999 May; 67(1):36-42. PubMed ID: 10329021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.
    Chu TH; Martinez I; Sheay WC; Dornburg R
    Gene Ther; 1994 Sep; 1(5):292-9. PubMed ID: 7584094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor targeting of baculovirus displaying a lymphatic homing peptide.
    Mäkelä AR; Enbäck J; Laakkonen JP; Vihinen-Ranta M; Laakkonen P; Oker-Blom C
    J Gene Med; 2008 Sep; 10(9):1019-31. PubMed ID: 18655234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
    Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
    J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
    Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
    Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein.
    Kameyama Y; Kawabe Y; Ito A; Kamihira M
    J Virol Methods; 2008 Oct; 153(1):49-54. PubMed ID: 18606189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting HSV amplicon vectors.
    Grandi P; Spear M; Breakefield XO; Wang S
    Methods; 2004 Jun; 33(2):179-86. PubMed ID: 15121173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
    Suzuki S; Shimada T
    Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein.
    Conner J; Braidwood L; Brown SM
    Gene Ther; 2008 Dec; 15(24):1579-92. PubMed ID: 18701918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-order Sindbis vector targeting.
    Wickham T
    Nat Biotechnol; 1997 Aug; 15(8):717. PubMed ID: 9255777
    [No Abstract]   [Full Text] [Related]  

  • 20. Baculoviral display of functional scFv and synthetic IgG-binding domains.
    Mottershead DG; Alfthan K; Ojala K; Takkinen K; Oker-Blom C
    Biochem Biophys Res Commun; 2000 Aug; 275(1):84-90. PubMed ID: 10944446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.